Skip to main content

Regulatory & Access Resources

Browse our regulatory & access resources to find the latest articles, blogs, brochures, and videos from our experts. See the latest content below.

What COVID Taught Us About Focus, Innovation, and Leadership

Well before the COVID-19 pandemic struck in early 2020, drug developers were struggling to become more efficient. At industry conferences, executives, regulators, and investigators lauded new approaches, including decentralized trials (DCTs), patient centricity, adaptive study designs, and risk-based central monitoring. Still, uptake lagged.